News
Stocks
Artificial intelligence
Electric vehicles
Tech
Earnings reports
Indices
IPOs
Crypto
Bitcoin
Ethereum
XRP
Solana
Regulations
Industry
Economy
USA
UK
Europe
Asia Pacific
Africa
Global economy
Other
Commodities
Forex
Geopolitics
Interviews
Press releases
Sponsored
Knowledge hub
Crypto
Best crypto exchanges
Best crypto wallets
Best crypto apps
Best crypto signal providers
Best crypto to buy now
Best crypto presales
Trading
Best trading platforms
Best trading apps
Best CFD trading platforms
Best day trading platforms
Best islamic trading platforms
Best MT4 brokers
Best demo trading accounts
Best options trading platforms
Best copy trading platforms
Best forex brokers
Best forex signals
Best commodity trading platforms
Best prop trading firms
Investing
Best investment apps
Best investment platforms
Best ETF platforms
Best robo-advisors
How to guides
How to invest in SpaceX
How to buy cryptocurrency
How to Buy Bitcoin (BTC) in 2026
Buy Bitcoin with PayPal
Buy Bitcoin with credit card
Buy Bitcoin with Amex
Buy Bitcoin with Google Pay
Buy Bitcoin with Apple Pay
Buy Bitcoin with Afterpay
Buy Bitcoin with Amazon Pay
Reviews
Top reviews
Plus500 review
eToro review
Kraken review
Coinbase review
Gemini review
Interactive Brokers review
Binance review
Crypto.com review
Tastyfx review
All reviews
Cryptostake review
Charles Schwab review
FTMO review
FundedNext review
Ledger Nano S review
OKX review
Public.com review
Robinhood review
Uphold review
Tradit review
About
Who we are
About
Our team
Our methodology
Our editorial policy
Advertising
Acquisitions & mergers
RSS feeds
Social media
X
Facebook
Telegram
YouTube
LinkedIn
Google news
Zero Sum Podcast
Spotify
YouTube
Zero Sum Podcast
Spotify
YouTube
Health & pharma news, analysis, & market updates
Health & pharma
Stock markets
Cryptocurrency
Economy
Trading ideas
Forex
Commodities
AI
Bonds
Features
Press releases
May 12, 2026, 07:48 AM
Stock market
Hims & Hers tumbles 15% after earnings miss as GLP-1 transition weighs on results
Apr 21, 2026, 15:31 PM
Stock market
Amazon shakes GLP-1 race as Eli Lilly, Novo Nordisk stocks fall
Apr 14, 2026, 03:27 AM
Health & pharma
Novo Nordisk taps OpenAI to boost AI in drug development
Apr 07, 2026, 10:39 AM
Health & pharma
Can Wegovy HD 7.2 mg drive Novo Nordisk’s obesity drug rebound?
Apr 01, 2026, 07:29 AM
Stock market
Novo Nordisk stock surges 4%: can NHS boost offset pricing pressure?
Mar 31, 2026, 12:24 PM
Health & pharma
Eli Lilly stock rises after $7.8B Centessa deal—bet on sleep drugs
Mar 31, 2026, 09:06 AM
Health & pharma
Novo cuts Ozempic, Wegovy prices up to 48% as generics surge
Mar 30, 2026, 03:54 AM
Artificial intelligence
Eli Lilly inks $2.75B AI deal with Insilico, bets on China biotech
Mar 27, 2026, 10:55 AM
Stock market
AstraZeneca stock jumps as COPD drug trial win surprises market
Mar 17, 2026, 11:42 AM
Health & pharma
Eli Lilly falls after a 6 month rally; is this a buy the dip opportunity?
Mar 16, 2026, 13:26 PM
Stock market
Why did Cingulate stock skyrocket today?
Mar 09, 2026, 13:27 PM
Stock market
Hims & Hers stock: why today's gains are unlikely to be sustainable
Mar 09, 2026, 09:23 AM
Stock market
Hims stock jumps 50% as Novo Nordisk ends lawsuit, strikes deal
Mar 04, 2026, 06:25 AM
Health & pharma
Moderna stock rallies after patent settlement removes overhang
Feb 23, 2026, 09:41 AM
Health & pharma
Eli Lilly bets on multi-dose Zepbound pen in GLP-1 retention push
Feb 23, 2026, 09:11 AM
Health & pharma
Merck creates separate oncology arm ahead of Keytruda patent loss
Feb 23, 2026, 05:45 AM
Stock market
Novo stock drops 15% as obesity drug falls short in key trial
Feb 17, 2026, 23:13 PM
Stock market
Danaher stock: 3 ways Masimo deal could boost stock
Feb 10, 2026, 08:57 AM
Earnings reports
CVS Health beats expectations as turnaround strategy gains traction
Feb 09, 2026, 09:00 AM
Europe
What analysts think of Novo, Him & Hers after obesity pill withdrawal
Feb 05, 2026, 14:29 PM
Health & pharma
Why a $49 weight-loss pill is rattling Novo Nordisk and Eli Lilly
Feb 05, 2026, 13:43 PM
Airline
Evening digest: Bitcoin crashes, weight-loss drug price war, Saudia’s fleet expansion
Feb 04, 2026, 14:03 PM
Central banks
Europe bulletin: Eli Lilly’s blockbuster Q4, FTSE 100 at record, UK growth picks up
Feb 04, 2026, 09:14 AM
Health & pharma
Eli Lilly beats earnings, lifts outlook on booming Zepbound and Mounjaro sales
Feb 03, 2026, 14:16 PM
Asia Pacific
Evening digest: Walmart's $1T mark, Novo's weak outlook, Bitcoin slips below $74K
No results found
Loading articles...
Failed to load articles. Please try again.
Load More
Load More